Chongqing Kangwei Expects Approval for H. Pylori Vaccine

Published: Sep 13, 2007

September 13, 2007 -- According to reports, China’s State Food and Drug Administration (SFDA) will issue its verdict in September on a preventative vaccine for Helicobacter pylori from Chongqing Kangwei Biotechnology. H. pylori causes ulcers and other gastic disorders. The decision is expected to be positive. More details...

Back to news